Related Experiment Video
Updated: May 19, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating
Maiko Hasegawa-Moriyama1, Tetsuya Ohnou, Kohei Godai
1Department of Anesthesiology and Critical Care Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan. hase-mai@m3.kufm.kagoshima-u.ac.jp
Abstract:
Acute inflammation triggered by macrophage infiltration to injured tissue promotes wound repair and may induce pain hypersensitivity. Peroxisome proliferator-activated receptor γ (PPAR)γ signaling is known to regulate heterogeneity of macrophages, which are often referred to as classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages have considerable antimicrobial activity and produce a wide variety of proinflammatory cytokines. In contrast, M2 macrophages are involved in anti-inflammatory and homeostatic functions linked to wound healing and tissue repair. Although it has been suggested that PPARγ agonists attenuate pain hypersensitivity, the molecular mechanism of macrophage-mediated effects of PPARγ signaling on pain development has not been explored. In this study, we investigated the link between the phenotype switching of macrophage polarization induced by PPARγ signaling and the development of acute pain hypersensitivity. Local administration of rosiglitazone significantly ameliorated hypersensitivity to heat and mechanical stimuli, and paw swelling. Consistent with the down-regulation of nuclear factor κB (NFκB) phosphorylation by rosiglitazone at the incisional sites, the number of F4/80(+)iNOS(+) M1 macrophages was decreased whereas numbers of F4/80(+)CD206(+) M2 macrophages were increased in rosiglitazone-treated incisional sites 24 h after the procedure. In addition, gene induction of anti-inflammatory M2-macrophage-associated markers such as arginase1, FIZZ1 and interleukin (IL)-10 were significantly increased, whereas M1-macrophage-related molecules such as integrin αX, IL-1β, MIP2α and leptin were decreased at rosiglitazone-treated incisional sites. Moreover, transplantation of rosiglitazone-treated peritoneal macrophages into the incisional sites significantly attenuated hyperalgesia. We speculate that local administration of rosiglitazone significantly alleviated the development of postincisional pain, possibly through regulating macrophage polarity at the inflamed site. PPARγ signaling in macrophages may be a potential therapeutic target for the treatment of acute pain development.
Insights
Peroxisome proliferator-activated receptor γ (PPAR)γ signaling, regulated by rosiglitazone, shifts macrophages from M1 to M2, reducing acute pain and inflammation. This suggests PPARγ signaling is a potential therapeutic target for pain management.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Macrophage polarization (M1/M2) influences inflammation and pain.
- Peroxisome proliferator-activated receptor γ (PPARγ) signaling modulates macrophage phenotypes.
- The role of PPARγ in macrophage-mediated pain development remains unclear.
Purpose of the Study:
- To investigate the link between PPARγ signaling, macrophage polarization, and acute pain hypersensitivity.
- To explore the molecular mechanisms underlying PPARγ's effects on pain development.
Main Methods:
- Local administration of rosiglitazone (a PPARγ agonist) in a mouse incisional pain model.
- Assessment of pain hypersensitivity (heat, mechanical), paw swelling, and macrophage markers (F4/80, iNOS, CD206).
- Analysis of M1/M2-associated gene expression and macrophage transplantation.
Main Results:
- Rosiglitazone significantly reduced pain hypersensitivity, swelling, and M1 macrophage markers.
- Rosiglitazone increased M2 macrophage markers and anti-inflammatory gene expression.
- Transplantation of treated macrophages attenuated hyperalgesia, confirming macrophage-mediated effects.
Conclusions:
- PPARγ signaling, via rosiglitazone, alleviates acute post-incisional pain by promoting M2 macrophage polarization.
- PPARγ signaling in macrophages represents a potential therapeutic target for acute pain development.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
